France· FR:60798510
SUSTIVA 50 mg, gélule
A efavirenz product containing éfavirenz, registered in France by BRISTOL-MYERS SQUIBB PHARMA (IRLANDE). The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Efavirenz is registered in 16 of 19 countries.
Countries holding a registration under ATC J05AG03 (efavirenz), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Efavirenz · ATC J05AG03
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of efavirenz costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $9.90 in Switzerland to $66.82 in France — a ×6.7 gap.
- France: $66.82 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Efavirenz · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- FR France$66.82
- CH Switzerland$9.90
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉFAVIRENZ
- Manufacturer
- BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- Country
- France (FR)
- ATC code
- J05AG03
- ATC class
- Efavirenz
- Defined daily dose
- 0.6 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009351768991 flacon(s) polyéthylène haute densité (PEHD) de 30 gélule(s) avec fermeture de sécurité enfant
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
486 interactions on record for efavirenz.
Graded by severity as the source publishes them — 137 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Efavirenz · interactions on record
486 records
- 137 severe
- 278 moderate
- 8 minor
- 48 info
Most severe, free to view
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
15 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Efavirenz in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandStocrinMerck Sharp & Dohme B.V.
- BelgiumStocrin 50 mgMerck Sharp & Dohme
- SpainSUSTIVA 50 mg, CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- United KingdomSustiva 50mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsStocrin 50 mg, capsulesMerck Sharp & Dohme B.V.
- PolandSustivaBristol-Myers Squibb Pharma EEIG
- United StatesEfavirenzAurobindo Pharma Limited
- DenmarkSustivaBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Efavirenz Sandoz
- Belgium · Efavirenz Viatris
- Cyprus · Efavirenz Aurobindo
- Germany · Efavirenz Aurobindo
- Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
- Estonia · Efavirenz Sandoz
- Spain · Efavirenz Aurovitas
- Finland · Efavirenz Aurobindo, Efavirenz Sandoz
- United Kingdom (Northern Ireland) · Efavirenz Accord, Efavirenz Amarox
- Iceland · Efavirenz Teva
- Liechtenstein · Efavirenz Teva
- Netherlands · Efavirenz Accord, Efavirenz Aurobindo
- Norway · Efavirenz Sandoz, Efavirenz Teva
- Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
- Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ffcc683c-3e0b-4197-a6f2-378f8e7ae776 GET /v1/drugs/ffcc683c-3e0b-4197-a6f2-378f8e7ae776?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60798510",
"date_amm": "1999-05-28",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/99/110",
"substance": "ÉFAVIRENZ",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.